P

Inventor

BENNETT JEAN

US30 patents
⚠️ This page may combine multiple inventors who share the name “BENNETT JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV PENNSYLVANIA

21 patents
US9567376B2Feb 14, 2017

Enhanced AAV-mediated gene transfer for retinal therapies

UNIV PENNSYLVANIA48 citations93
US10266845B2Apr 23, 2019

Enhanced AAV-mediated gene transfer for retinal therapies

UNIV PENNSYLVANIA13 citations80
US10155794B2Dec 18, 2018

Compositions and methods for treatment of disorders related to CEP290

UNIV PENNSYLVANIA5 citations80
US10987433B2Apr 27, 2021

Compositions and methods for correction of heritable ocular disease

UNIV PENNSYLVANIA4 citations69
US10301366B2May 28, 2019

Compositions and methods for treatment of disorders related to CEP290

UNIV PENNSYLVANIA2 citations69
US11197936B2Dec 14, 2021

Methods and compositions for treatment of disorders and diseases involving RDH12

UNIV PENNSYLVANIA3 citations68
US9896665B2Feb 20, 2018

Proviral plasmids and production of recombinant adeno-associated virus

UNIV PENNSYLVANIA2 citations68
US10392622B2Aug 27, 2019

Compositions and methods for self-regulated inducible gene expression

UNIV PENNSYLVANIA4 citations64
US11879133B2Jan 23, 2024

Gene therapy for ocular disorders

UNIV PENNSYLVANIA2 citations63
US12403204B2Sep 2, 2025

Gene therapy for ocular disorders

UNIV PENNSYLVANIA0 citations60
US12097267B2Sep 24, 2024

Methods and compositions for treatment of ocular disorders and blinding diseases

UNIV PENNSYLVANIA0 citations60
US11827898B2Nov 28, 2023

Gene therapy for ocular disorders

UNIV PENNSYLVANIA0 citations60
US11090392B2Aug 17, 2021

Gene therapy for ocular disorders

UNIV PENNSYLVANIA0 citations60
US9433688B2Sep 6, 2016

Method of treating or retarding the development of blindness

UNIV PENNSYLVANIA2 citations60
US12533423B2Jan 27, 2026

Neuroprotective gene therapy targeting the AKT pathway

UNIV PENNSYLVANIA0 citations58
US12419973B2Sep 23, 2025

Methods and compositions for treatment of disorders and diseases involving RDH12

UNIV PENNSYLVANIA0 citations58
US11564996B2Jan 31, 2023

Gene therapy for ocular disorders

UNIV PENNSYLVANIA0 citations54
US11206977B2Dec 28, 2021

Vision test for determining retinal disease progression

UNIV PENNSYLVANIA0 citations52
US11793887B2Oct 24, 2023

Gene therapy for treating peroxisomal disorders

UNIV PENNSYLVANIA0 citations50
US10857240B2Dec 8, 2020

Methods and compositions for treatment of ocular disorders and blinding diseases

UNIV PENNSYLVANIA0 citations50
US12558434B2Feb 24, 2026

Compositions for treatment of wet age-related macular degeneration

UNIV PENNSYLVANIA0 citations41

BENNETT JEAN

2 patents

ASCIDIAN THERAPEUTICS INC

2 patents

UNIV YALE

1 patent

BENNETT JR WILLIAM R

1 patent

ACLAND GREGORY M

1 patent

INST NAT SANTE RECH MED

1 patent

CHILDRENS HOSPITAL PHILADELPHIA

1 patent